Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  January 6, 2025
Memoranda
2025 Forecast for U.S. Federal and International Chemical Regulatory Policy

Bergeson & Campbell, P.C. (B&C®), its global consulting affiliate The Acta Group (Acta®), and consortia management affiliate B&C®...

  July 22, 2024
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  December 31, 2024
Memoranda
Maine Proposes Rule Regarding Products Containing Intentionally Added PFAS

On December 20, 2024, the Maine Department of Environmental Protection (MDEP) published a proposed rule regarding products containing intentionally...

  December 23, 2024
Memoranda
EPA Requires Submission of Health and Safety Studies for 16 Chemicals Being Considered for Risk Evaluation under TSCA

On December 13, 2024, the U.S. Environmental Protection Agency (EPA) published a final Health and Safety Reporting Rule under the Toxic Substances...

  December 12, 2024
Memoranda
EPA Begins Public Consultation on Interim Framework for Advancing Consideration of Cumulative Impacts

On November 21, 2024, the U.S. Environmental Protection Agency (EPA) released a draft Interim Framework for Advancing Consideration of Cumulative...

  December 11, 2024
Memoranda
Senate Subcommittee Holds Hearing on Public Health Impacts of PFAS Exposures

On December 5, 2024, the Senate Environment and Public Works (EPW) Subcommittee on Chemical Safety, Waste Management, Environmental Justice, and...

  December 10, 2024
Memoranda
EPA Releases Final Supplement to the Risk Evaluation and Revised Unreasonable Risk Determination for 1,4-Dioxane

On November 13, 2024, the U.S. Environmental Protection Agency (EPA) announced the release of its final supplement to the risk evaluation and revised...

Seminars & Webinars

  November 19, 2024
Seminars & Webinars
What to Expect When You Don’t Know What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025, January 14, 2025, 11:00 a.m. – 12:00 p.m. (EST), via webinar

Registration is now open for Acta and B&C’s “What to Expect When You Don’t Know What to Expect in Chemicals Policy and Regulation and on...

  December 20, 2024
Seminars & Webinars
What’s New with New Approach Methodologies: A Webinar, February 13, 2025 11:00 a.m. – 12:30 p.m. (EST), via webinar

B&C and Acta are pleased to present “What’s New with New Approach Methodologies: A Webinar.” More details will be posted closer to the...

  December 20, 2024
Seminars & Webinars
Environmental Law 2025: Tackling the Issues in a Pivotal Year, February 20 – 21, 2025, Washington, D.C. and via webcast

ALI CLE presents “Environmental Law 2025: Tackling the Issues in a Pivotal Year,” a two-day program on what lies ahead in a pivotal year for...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.